"Today, Ministry of Healthcare of Russia has registered the fourth Russian vaccine for prevention of the new coronavirus infection - Sputnik Light, created by the National Research Centre for Epidemiology and Microbiology. Unlike the two-component vaccine Sputnik-V, Sputnik Light only consists of one component based on the 26th type of adenovirus. Based on the result of conducted pre-clinical and clinical trials, Sputnik Light vaccine enjoys favorable safety profile, and all volunteers developed the cellular immune response to the trigger of SARS-CoV-2", he said.
According to the minister, the registration of the fourth Russian vaccine will expand the available arsenal of drugs for the prevention of coronavirus and speed up the formation of a stable collective immunity.
In late February, the Russian fund of direct investments submitted an appeal for registration of the drug, and the trials on volunteers began. On March 29, the Russian Healthcare Ministry started the registration procedure.
Russia had previously registered three vaccines against Covid-19 - Sputnik V, EpiVacCorona, and CoviVac.